SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-21-007304
Filing Date
2021-02-23
Accepted
2021-02-23 08:11:02
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 ATM odt-424b5.htm 424B5 260530
2 GRAPHIC gq4sd0hscika000003.jpg GRAPHIC 4471
3 GRAPHIC gq4sd0hscika000002.jpg GRAPHIC 32370
4 GRAPHIC gq4sd0hscika000004.jpg GRAPHIC 27688
5 GRAPHIC gq4sd0hscika000001.jpg GRAPHIC 4757
6 GRAPHIC gq4sd0hscika000005.jpg GRAPHIC 4757
  Complete submission text file 0001564590-21-007304.txt   364477
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233990 | Film No.: 21663170
SIC: 2834 Pharmaceutical Preparations